BTAX (Biostax) GF Value : $0.00 (As of Dec. 14, 2024)

View and export this data going back to . Start your Free Trial

What is Biostax GF Value?

As of today (2024-12-14), Biostax's share price is $0.01895. Biostax's GF Value is $0.00. Therefore, Biostax's Price-to-GF-Value for today is . Based on the relationship between the current stock price and the GF Value, GuruFocus believes Biostax is Not Valued.

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

Biostax (OTCPK:BTAX) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Biostax's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.01895	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biostax GF Value Related Terms

Thank you for viewing the detailed overview of Biostax's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Biostax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792

Website

https://www.biostaxcorp.com

Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.

Executives

Glen A Farmer	officer: Chief Financial Officer	20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
H. Louis Salomonsky Jr. Revocable Trust	10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Henry Louis Salomonsky	director, 10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Kelly O'brien Wilson	10 percent owner, officer: COO and ICEO and IP	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
James Norman Curley	other: Member of 10% owner group	410 DAHLIA AVE, CORONA DEL MAR CA 92625
Empower Insurance Corp Ltd	other: Member of 10% owner group	1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ
Global Reverb Corp	10 percent owner, other: Member of 10% owner group	100 S EOLA DR, UNIT 1703, ORLANDO FL 32801
Paul Puskadi	other: Member of 10% owner group	2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004
Deane Rhodes	other: Member of 10% owner group	9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406
Roger Dale Bozarth	other: Member of 10% owner group	9028 GREAT HERON CIR, ORLANDO FL 32836
Joel Yanowitz	other: Member of 10% owner group	100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925
Rogoff Family Trust Dtd	other: Member of 10% owner group	20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255
George Sasko	other: Member of 10% owner group	515 WESTCHESTER DR, STE D, CAMPBELL CA 95008
Raster Investments, Inc	other: Member of 10% owner group	2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736
Robert Jackman Dailey	other: Member of 10% owner group	401 FIRST STREET, LOS ALTOS CA 94022